Paul A. Bonneau

FDA investigator

Appears on 5 documents from 2003 to 2016, most often at sites in Arizona. Most often cites control of microbiological contamination (21 CFR 211.113).

5
Documents on file
5.4
Observations per 483
2003
First seen
2016
Most recent

What they cite most

From 26 observations

Activity by year

2003: 1, 2014: 1, 2015: 2, 2016: 1

Where

Arizona 1 · California 1 · France 1 · Georgia 1 · Texas 1

Is Paul A. Bonneau coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Laboratoires Merck Sharp & Dohme ChibretJan 19, 2016 · Riom, France
483 Pacira Pharmaceuticals, Inc.Jul 22, 2015 · San Diego, California
483 CareFusion 213, LLCJun 25, 2015 · El Paso, Texas
483 Form 483 · FEI 3007200605Dec 2, 2014 · Mesa, Arizona
483 CryoLife, Inc.Feb 14, 2003 · Kennesaw, Georgia

About this profile

What does Paul A. Bonneau inspect?

Paul A. Bonneau appears on 5 documents on file covering 5 sites, most often in Arizona.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 1271.200 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Paul A. Bonneau is dated Jan 19, 2016.